Sodium-Glucose Cotransporter-2 Inhibitors Improve Cardiovascular Dysfunction in Type 2 Diabetic East Asians

Sodium-Glucose Cotransporter-2 Inhibitors Improve Cardiovascular Dysfunction in Type 2 Diabetic East Asians

In East Asians, the incidence of type 2 DM (T2DM) has increased as a result of major alterations in life. Cardiovascular problems are more likely in those with T2DM. Sodium-glucose cotransporter-2 (SGLT2) inhibitors are novel insulin-independent antihyperglycemic drugs that limit renal glucose reabs...

Full description

Bibliographic Details
Main Authors: Muhammad Afzal, Fahad A. Al-Abbasi, Muhammad Shahid Nadeem, Sultan Alshehri, Mohammed M. Ghoneim, Syed Sarim Imam, Waleed Hassan Almalki, Imran Kazmi
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Metabolites
Subjects:
cardioprotection
East Asians
diabetes mellitus
SGLT2 inhibitors
insulin independent
Online Access:https://www.mdpi.com/2218-1989/11/11/794

Internet

https://www.mdpi.com/2218-1989/11/11/794

Similar Items